Results 231 to 240 of about 91,344 (325)
This study investigated the prognostic value of the preoperative prognostic immune nutritional index (PINI) in colorectal cancer. A low preoperative PINI was significantly associated with both poor oncological outcomes and an increased risk of postoperative infectious complications.
Shinji Yamashita +9 more
wiley +1 more source
Carcinoembryonic Antigen (CEA): Origin, Role in Oncology, and Concentrations in Serum and Peritoneal Fluid. [PDF]
Niedzielska J, Jastrzębski T.
europepmc +1 more source
Carcinoembryonic antigen in differential diagnosis of carcinoma of pancreas from chronic pancreatitis. [PDF]
J B Dilawari +3 more
openalex +1 more source
This multicenter study suggests that adjuvant chemotherapy may improve survival in stage IV intrahepatic cholangiocarcinoma after resection, with S‐1 showing a potential survival advantage. ABSTRACT Background The survival benefit of adjuvant chemotherapy (AC) in intrahepatic cholangiocarcinoma (ICC) remains uncertain, particularly in advanced‐stage ...
Hisashi Kosaka +9 more
wiley +1 more source
Head-to-head comparison of the diagnostic accuracy of pleural fluid, serum carcinoembryonic antigen, and their ratio for malignant pleural effusion: a systematic review and meta-analysis. [PDF]
Yang DN +12 more
europepmc +1 more source
The utility of serum tumor markers in esophageal squamous cell carcinoma and gastric cancer were evaluated by systematic review and meta‐analysis. In addition, the position of each marker, strategies for improving their accuracy in the future, and new markers are also described.
Yasunori Matsumoto +2 more
wiley +1 more source
Developing cancer vaccine with carcinoembryonic antigen and IGF-1R as immunostimulants using immunoinformatics approach. [PDF]
Ezediuno LO +5 more
europepmc +1 more source
The Carcinoembryonic Antigen Level Among Tobacco Workers
Yıldız Pekşen +3 more
openalex +2 more sources
Long term response on Regorafenib in non-V600E BRAF mutated colon cancer: a case report [PDF]
Callebout, Eduard +7 more
core +2 more sources
ABSTRACT This case underscores the critical importance of retesting for resistant mechanisms, such as EML4‐ALK fusion, in patients with EGFR‐mutant lung adenocarcinoma who experience rapid progression on EGFR‐tyrosine kinase inhibitor (TKI) therapy. Early identification of such co‐alterations and an immediate switch to alectinib can lead to rapid and ...
Yuzhu Chen +6 more
wiley +1 more source

